$644,500,000 in Total Settlement Funds Available. See if you qualify!Find Out More

Lion Biotechnologies, Inc. (n/k/a Iovance Biotherapeutics, Inc.) Settlement
(NASDAQ: IOVA)
Settlement

Claim Deadline: March 22, 2019

Settlement Fund: $3,250,000

Settlement Class

All persons or entities that  purchased or otherwise acquired Lion Biotechnologies, Inc.  common stock and were damaged thereby during the period between September 27, 2013 and April  10, 2017, inclusive.

Important Documents

Settlement Status

Disbursed

Class Period

September 27, 2013 - April 10, 2017

Settlement Hearing Date

April 12, 2019

Opt-Out Deadline

March 15, 2019

Settlement Website

N/A

Claims Admin

JND Legal Administration
LION BIOTECHNOLOGIES  
SECURITIES LITIGATION SETTLEMENT 
c/o JND Legal Administration 
P.O. Box 91227
Seattle, WA 98111
+1 888-337-0001
info@LionBiotechnologiesLitigationSettlement.com

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.